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Light propagating in tissue attains a spectrum that varies with 
location due to wavelength-dependent fluence attenuation by 
tissue optical properties, an effect that causes spectral corruption. 
Predictions of the spectral variations of light fluence in tissue are 
challenging since the spatial distribution of optical properties in 
tissue cannot be resolved in high resolution or with high accuracy 
by current methods. Spectral corruption has fundamentally 
limited the quantification accuracy of optical and optoacoustic 
methods and impeded the long sought-after goal of imaging blood 
oxygen saturation (sO2) deep in tissues; a critical but still 
unattainable target for the assessment of oxygenation in 
physiological processes and disease. We discover a new principle 
underlying light fluence in tissues, which describes the 
wavelength dependence of light fluence as an affine function of a 
few reference base spectra, independently of the specific 
distribution of tissue optical properties. This finding enables the 
introduction of a previously undocumented concept termed 
eigenspectra Multispectral Optoacoustic Tomography (eMSOT) 
that can effectively account for wavelength dependent light 
attenuation without explicit knowledge of the tissue optical 
properties. We validate eMSOT in more than 2000 simulations 
and with phantom and animal measurements. We find that 
eMSOT can quantitatively image tissue sO2 reaching in many 
occasions a better than 10-fold improved accuracy over 
conventional spectral optoacoustic methods. Then, we show that 
eMSOT can spatially resolve sO2 in muscle and tumor; revealing 
so far unattainable tissue physiology patterns. Last, we related 
eMSOT readings to cancer hypoxia and found congruence 
between eMSOT tumor sO2 images and tissue perfusion and 
hypoxia maps obtained by correlative histological analysis.  
 
The assessment  of tissue oxygenation is crucial for 
understanding tissue physiology and characterizing a 
multitude of conditions  including cardiovascular disease, 
diabetes,  cancer hypoxia1 or metabolism. Today, tissue 
oxygenation (pO2) and hypoxia measurements remain 
challenging and often rely on invasive methods that may 
change the tissue physiology, such as single point needle 
polarography or immunohistochemistry2. Non-invasive 
imaging methods have been also considered, underscoring the 
importance of assessing pO2, but come with limitations. 
Positron emission tomography (PET) or single-photon 
emission computed tomography (SPECT) assess cell hypoxia 
by administration of radioactive tracers2, but are often not well 
suited for quantifying tissue oxygenation, suffer from low 
spatial resolution and are unable to provide longitudinal or 
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dynamic imaging capabilities. Electron paramagnetic 
resonance imaging3 can measure tissue pO2 but is not widely 
used due to limitations in spatial and temporal resolution. 
Imaging methods using tracers may be further limited by 
restricted tracer bio-distribution, in particular to hypoxic areas. 
Tracer-free modalities have also been researched, in particular 
BOLD MRI4, which however primarily assesses only 
deoxygenated hemoglobin and therefore presents challenges in 
quantifying oxygenation and blood volume5. 
Measurement of blood oxygenation levels (sO2) is a vital 
tissue physiology measurement and can provide an alternative 
way to infer tissue oxygenation and hypoxia. Arterial sO2 is 
widely assessed by the pulse oximeter, based on empirical 
calibrations, but this technology cannot be applied to 
measurements other than arterial blood. Optical microscopy 
methods like phosphorescence quenching microscopy6 or 
optoacoustic (photoacoustic) microscopy7 can visualize 
oxygenation in blood vessels and capillaries but are restricted 
to superficial (<1mm depth) measurements.  Diffuse optical 
methods received significant attention in the last two decades 
for sensing and imaging oxy- and deoxygenated hemoglobin 
deeper in tissue but did not yield sufficient accuracy because 
of  the low resolution achieved due to photon scattering8.   
 Multispectral optoacoustic tomography (MSOT) detects the 
spectra of oxygenated and deoxygenated  hemoglobin in high 
resolution deep within tissues, since signal detection and 
image reconstruction are not significantly affected by photon 
scattering 9,10. Despite the principal MSOT suitability for non-
invasive imaging of blood oxygenation, accuracy remains 
limited by the dependence of light fluence on depth and light 
color. Unless explicitly accounted for, the wavelength 
dependent light fluence attenuation with depth alters the 
spectral features detected and results in inaccurate estimates of 
blood sO2 11,12.  Despite at least two decades of research in 
optical imaging, the problem of light fluence correction has 
not been conclusively solved 9. To date this problem has been 
primarily studied from an optical property quantification point 
of view 13,12. However, it is not possible today to accurately 
image tissue optical properties in-vivo, in high-resolution, and 
compute light fluence12. Therefore, quantitative sO2 
measurement deep in tissue in-vivo remains an unmet 
challenge. Conventional spectral optoacoustic methods14,15 
typically ignore the effects of light fluence and employ linear 
spectral fitting with the spectra of oxy- and deoxy-hemoglobin 
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for estimating sO2 (linear unmixing), a common simplification 
that can introduce substantial errors in deep tissue. 
In this work we discovered a new principle of light fluence 
in tissue and exploit it to solve this fundamental quantification 
challenge of optical methods. In particular, we found that the 
spectral patterns of light fluence expected within the tissue can 
be modeled as an affine function of a few reference base 
spectra, independently of the specific distribution of tissue 
optical properties or the depth of the observation. We show 
how this principle can be employed to solve the spectral 
corruption problem without knowledge of the tissue optical 
properties, and significantly increase the accuracy of spectral 
optoacoustic methods. The proposed method, termed 
eigenspectra-MSOT (eMSOT), provides for the first time 
quantitative estimation of blood sO2 in deep tissue. We 
demonstrate the superior performance of the method with 
more than 2000 simulations, phantom measurements and in-
vivo controlled experiments. Then, using eMSOT, we image 
for the first time oxygen gradients in skeletal muscles in-vivo, 
previously only accessible through invasive methods.  
Furthermore, we show the application of eMSOT in 
quantifying blood oxygenation gradients in tumors during 
tumor growth or O2 challenge and relate label-free non-
invasive eMSOT readings to tumor hypoxia; demonstrating 
the ability to measure quantitatively the perfusion hypoxia 
level in tumors, as confirmed with invasive histological gold 
standards. 
RESULTS 
A new concept of treating light fluence in diffusive 
media/tissues is introduced, based on the observation that the 
light fluence spectrum at different locations in tissue depends 
on a cumulative light absorption operation by tissue 
chromophores, such as hemoglobin. We therefore 
hypothesized that there exists a small number of base spectra 
that can be combined to predict any fluence spectrum present 
in tissue; therefore avoiding the unattainable task of knowing 
the distribution of tissue optical properties at high resolution. 
To prove this hypothesis, we first applied Principal 
Component Analysis (PCA) on 1470 light fluence spectral 
patterns, which were computed by simulating light 
propagation in tissues at 21 different (uniform) oxygenation 
states of hemoglobin and 70 different discrete depths 
(Methods). PCA analysis yielded four significant base 
spectra, i.e. a mean light fluence spectrum (Figure 1a) and 
three fluence Eigenspectra (Figure 1b-d).   
We then postulated that light fluence spectra in unknown 
and non-uniform tissues can be modeled as a superposition of 
the mean fluence spectrum (ΦM) and the three Eigenspectra 
(Φi(λ), i=1..3)  multiplied by appropriate scalars m1, m2 and 
m3, termed Eigenfluence parameters. To validate this 
hypothesis we computed the light fluence in >500 simulated 
tissue structures of different and non-uniform optical 
properties and hemoglobin oxygenation values 
(Supplementary Note 1). For each pixel, we fitted the 
simulated light fluence spectrum to the Eigenspectra model 
and derived the Eigenfluence parameters (m1, m2, m3) and a 
fitting residual value. The residual value represents the error 
of the Eigenspectra model in matching the simulated data and 
typically assumed values below 1% (see Supplementary Note 
1) indicating that three Eigenspectra can accurately model all 
simulated fluence spectra generated in tissues of arbitrary 
structure.  We further observed that the values of m2 vary 
primarily with tissue depth while the values of m1 also depend 
on the average levels of background tissue oxygenation (see 
Figure 1f-h). Intuitively this indicates that the second 
Eigenspectrum Φ2(λ) is mainly associated with the 
modifications of light fluence spectrum due to  depth and the 
average optical properties of the surrounding tissue, while the 
first Eigenspectrum Φ1(λ)  is also associated with  the 
“spectral shape” of  light fluence that relates to the average 
oxygenation of the surrounding tissue. 
 Following these observations, we propose eigenspectra 
MSOT (eMSOT), based on three eigenspectra Φ1(λ), Φ2(λ), 
Φ3(λ), as a method that formulates the blood sO2 estimation 
problem as a non-linear spectral unmixing problem, i.e.  
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where P(r,λ) is the multispectral optoacoustic image intensity  
obtained at a position r and wavelength λ, εHbO2(λ) and  εHb(λ) 
are the wavelength dependent molar extinction coefficients of 
oxygenated and deoxygenated hemoglobin, c′HbO2(r) and 
c′Hb(r) are the relative concentrations of oxygenated and 
deoxygenated hemoglobin (proportional to the actual ones 
with regard to a common scaling factor, see Methods), and 
Φ′(r,λ)  = ΦM(λ)  + m1(r)Φ1(λ) + m2(r)Φ2(λ) + m3(r)Φ3(λ). Eq. 
(1) defines a non-linear inversion problem, requiring 
measurements at 5 wavelengths or more for recovering the 5 
unknowns, i.e. c'HbO2(r), c'Hb(r), m1(r), m2(r), m3(r) and is 
solved as a constrained optimization problem (Methods, 
Supplementary Note 2). For computational efficiency, we 
observe that the light fluence varies smoothly in tissue and 
only compute the Eigenfluence parameters on a coarse grid 
subsampling the region of interest (Figure 1i). Then, cubic 
interpolation is employed to compute the Eigenfluence 
parameters in each pixel within the convex hull of the grid 
(Figure 1j) and calculate a fluence spectrum Φ′(r,λ) for each 
pixel.  Eq. (1) is then solved for c′HbO2(r) and c′Hb(r) and sO2 is 
computed (see Methods).  
Using simulated data obtained from a light propagation 
model (finite element solution of the diffusion approximation) 
applied on >2000 randomly created maps of different optical 
properties, simulating different tissue physiological states, we 
found a substantially improved sO2 estimation accuracy of 
eMSOT over linear unmixing (Figure 1m & Supplementary 
Note 3). Especially in the case of tissue depths of >5mm 
eMSOT typically offered a 3-8 fold sO2 estimation accuracy 
improvement over conventional linear unmixing 
(Supplementary Figure 4n). Figure 1k depicts a 
representative example of a simulated blood sO2 map and 
visually showcases the differences between the eMSOT sO2 
image (middle),  the sO2 image obtained using linear unmixing 
(left) and the original sO2 simulated image (right). eMSOT 
offered  significantly lower sO2 estimation error with depth, 
compared to the linear fitting method (Figure 1l).   
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Figure 1. eMSOT concept and application. (a-d) The Eigenspectra model composed of a mean fluence spectrum ΦM(λ) (a) and the three 
fluence Eigenspectra Φ1(λ), Φ2(λ) and Φ3(λ), (b), (c), (d), respectively, as derived by applying PCA on a selected training data-set of light 
fluence spectra. (e) L2 norm error of the Eigenspectra model on the training dataset for different model dimensionalities. (f-h) Values of the 
parameters m1, m2 and m3 as a function of tissue depth (y axis) and tissue oxygenation (x axis). The values have been obtained after fitting the 
light fluence spectra of the training data-set (see Methods) to the Eigenspectra model.  (i) Application of a circular grid (red points) for eMSOT 
inversion on an area of a simulated MSOT image. (j) After eMSOT inversion the model parameters m1, m2 and m3 are estimated for all grid 
points and maps of m1, m2 and m3 are produced for the convex hull of the grid by means of cubic interpolation. These maps are used to 
spectrally correct the original MSOT image. (k) Blood sO2 estimation using linear unmixing (left), eMSOT (middle) and Gold standard sO2 
(right) of the selected region. (l) sO2 estimation error of the analyzed area sorted per depth in the case of linear unmixing (red points) and 
eMSOT (blue points). (m) Mean sO2 error of linear unmixing (red) and eMSOT (blue) corresponding to >2000 simulations of random 
structures and optical properties (see Supplementary Note 3). 
 
For experimentally assessing the accuracy of eMSOT, we 
performed a series of blood phantom experiments that suggest 
an up to 10-fold more reliable sO2 estimation derived by 
eMSOT, as compared to conventional linear unmixing 
(Supplementary Note 4). In addition, controlled mouse 
measurements (n=4) were performed in-vivo,  under gas 
anesthesia, by rectally inserting capillary tubes containing 
blood at 100% and 0% sO2 levels (Methods). The mice were 
imaged in the lower abdominal area under 100%O2 and 20% 
O2 breathing conditions (Figure 2a). Figure 2a showcases the 
eMSOT grid applied on the images processed (left column), 
the sO2 maps obtained with linear unmixing (middle column) 
and with eMSOT (right column). The spectral fitting of linear 
unmixing (left) and eMSOT (right) corresponding to a pixel in 
the area of the capillary tube (yellow arrows in a) are 
presented in Figure 2b along with the estimated sO2 values. In 
the controlled in-vivo experiments, the mean linear unmixing 
error ranged from 16 to 35% while eMSOT offered a mean 
sO2 error ranging from 1 - 4% indicating an order of 
magnitude improved accuracy (Figure 2c). 
 
4 
 
 
Figure 2. Comparison of eMSOT sO2 estimation accuracy over 
conventional spectral optoacoustic method. (a) eMSOT application 
in the case of in-vivo controlled experiments under 100% O2 (a upper 
row) and 20% O2 (a lower row) breathing. Capillary tubes containing 
blood of 100% sO2 (upper row) and 0% sO2 (lower row) were 
inserted within tissue (arrows). Scale bar 1cm. (b) Spectral fitting and 
sO2 estimation in the insertion area (yellow arrows in a) using linear 
unmixing (left column) and eMSOT (right column). The blue curves 
correspond to P(r,λ) (left column) and PeMSOT(r,λ) (right column) 
while the red curves correspond to cHbO2lu(r)εHbO2(λ)+cHblu(r)εHb(λ) 
(left column; the term lu refers to linear unmixing) and 
c'HbO2eMSOT(r)εHbO2(λ)+c'HbeMSOT(r)εHb(λ) (right column). (c) sO2 
estimation error using eMSOT (blue) and linear unmixing (red) in all 
four animal experiment repetitions. 
 
Blood oxygenation and oxygen exchange in the 
microcirculation have been traditionally studied through 
invasive, single-point  polarography or microscopy 
measurements in vessels and capillaries of the skeletal 
muscle16. Research for macroscopic methods that could non-
invasively resolve muscle oxygenation was broadly pursued in 
the past two decades by considering Near-Infrared 
Spectroscopy (NIRS) and Diffuse Optical Tomography (DOT) 
17,18, which, however did not produce solutions yielding high 
fidelity or resolution. In a next set of experiments we, 
therefore, studied whether eMSOT could non-invasively 
quantify the oxygenation gradient in the skeletal muscle and 
we compared this performance to conventional spectral 
optoacoustic methods. The hindlimb muscle of 6 nude mice 
was imaged in-vivo under 100% O2, 20% O2 challenge; three 
of the mice were then sacrificed with an overdose of CO2, the 
latter binding to hemoglobin and deoxygenating blood.   
eMSOT resolved oxygenation gradients in the muscle, as a 
function of breathing  conditions in-vivo (Figure 3 b-c)  and 
post-mortem after CO2 breathing (Figure 3d). The post-
mortem deoxygenated muscle served herein as a control 
experiment and was also analyzed with linear unmixing for 
comparison (Figure 3e). In the post-mortem case, linear 
unmixing overestimated the sO2 as a function of tissue depth 
(Figure 3e) and yielded large errors in matching the tissue 
spectra (Figure 3f – upper row). Conversely, eMSOT offered 
sO2 measurements in agreement with the expected 
physiological states (Figure 3b-d) and consistently low fitting 
residuals (Figure 3f – lower row, Supplementary Figure 6).  
Figure 3d-e and Figure 3f demonstrate the prominent effects 
of spectral corruption with depth that impair the accuracy of 
conventional spectral optoacoustic methods but are tackled by 
eMSOT. The estimated blood sO2 values corresponding to a 
deep tissue area (yellow rectangle in Figure 3b) are tabulated 
in Figure 3g  for eMSOT and linear unmixing and depict that 
the latter demonstrated unrealistically small sO2 changes 
between the normoxic in-vivo and anoxic post-mortem (after 
CO2 breathing) states.  
In addition to physiological tissue features, MSOT also 
reveals tissue morphology. MSOT images at a single 
wavelength (900 nm) captured prominent vascular structures 
likely corresponding to femoral vessels or their branches 
(Figure 3h) with implicitly co-registered eMSOT blood-
oxygenation images. This hybrid mode enables the study of 
physiology at specific tissue areas. We selected to study blood 
oxygenation measurements at a region of interest around large 
vessels (ROI-1; Figure 3h) and a region of interest within the 
muscle presenting no prominent vascular structures (ROI-2; 
Figure 3h) for the 100% O2, 20% O2 and CO2 breathing 
conditions. Average tissue sO2 was typically measured at 
60%-70% saturation under medical air breathing and at 70%-
80% saturation under 100%O2 breathing near large vessels 
(Figure 3j). Average tissue blood oxygenation away from 
large vessels (ROI-2) was estimated consistently lower, at 35 -
50% saturation under normal breathing conditions and 45-60% 
saturation under 100%O2 breathing (Figure 3k). These are 
first observations of quantitative high-resolution blood-
oxygenation spatial gradients imaged non-invasively in tissue.  
The low blood saturation values in tissue (35 -50%) cannot 
be explained by considering arterial and venous blood 
saturation. However, previous studies based on direct 
microscopy measurements in vessels and capillaries through 
polarography, hemoglobin spectrophotometry and 
phosphorescence quenching microscopy have revealed  
similar oxygenation gradient in the skeletal muscle 16 with 
hemoglobin saturation in the femoral artery found to range 
between 87-99% sO216,19, while rapidly dropping down to 50-
60% sO2 in smaller arterioles 19,20.  The average oxygen 
saturation in venules and veins has been found to range 
between 45%-60% sO2 under normal breathing conditions, 
reaching up to 70% at 100% O2 breathing 20,21. Average 
capillary blood oxygenation has been estimated at 40% sO2 
with a large standard deviation 21, often reported lower, at an 
average, than venular oxygenation16. Therefore, the eMSOT 
values measured at ROI-1 possibly relate to a weighted 
average of arterial/arteriolar and venous/venular sO2 in 
skeletal muscle, while the values measured at ROI-2, which 
anatomically presents no prominent vasculature, relate more to 
capillary sO2 measurements.   
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Figure 3. eMSOT measurements of tissue blood oxygenation in the muscle. (a-d) eMSOT grid applied on the area of the hindlimb muscle 
(a) and eMSOT tissue blood sO2 estimation in the case of 100% O2 breathing (b), 20% O2 breathing (c) and post-mortem after CO2 breathing 
(d). (e) sO2 estimation using linear unmixing in the post mortem case after CO2 breathing. Scale bar 1cm. (f) Spectral fitting and sO2 values of 
linear unmixing (upper row) and eMSOT (lower row) for the three points indicated in (d) and (e). The blue curves correspond to P(r,λ) (upper 
row) and PeMSOT(r,λ) (lower row) while the red curves correspond to cHbO2lu(r)εHbO2(λ)+cHblu(r)εHb(λ) (upper row) and 
c'HbO2eMSOT(r)εHbO2(λ)+c'HbeMSOT(r)εHb(λ) (lower row). (g) Estimated blood sO2 of a deep tissue area (yellow box in b) using eMSOT (blue) and 
linear unmixing (red). (h) Anatomical MSOT image of the hindlimb area at an excitation wavelength of 900 nm. Two regions were selected for 
presenting the sO2 values, one close to prominent vasculature (ROI-1) and one corresponding to soft tissue (ROI-2). Scale bar 0.5cm. (i) 
eMSOT sO2 estimation in-vivo under 100% (left) and 20% O2 breathing (middle) and post-mortem after CO2 breathing (right). Scale bar 0.5cm. 
(j, k) Estimated tissue sO2 of ROI-1 (j) and ROI-2 (k) under 100% (red) and 20% O2 breathing (green) and post-mortem after CO2 breathing 
(blue). Measurements correspond to 6 different animals. 
 
The improved accuracy observed in eMSOT over previous 
approaches and general agreement with invasive tissue 
measurements prompted the further study of perfusion 
hypoxia emerging from the incomplete delivery of oxygenated 
hemoglobin in tissue areas. We hypothesized that 
measurements of blood saturation could be employed as a 
measure of tissue hypoxia, assuming natural hemoglobin 
presence in hypoxic areas. To examine this hypothesis we 
applied eMSOT to measure blood oxygenation in 4T1 solid 
tumors orthotopically implanted in the mammary pad of 8 
mice (Methods, Supplementary Note 6). MSOT revealed the 
tumor anatomy and heterogeneity, which was found consistent 
to anatomical features identified through cryoslice color 
photography and H&E staining (Supplementary Note 6). 
Furthermore, imaging tumors at different time-points revealed 
the progression of hypoxia during tumor growth (Figure 4a-
b). The spread of hypoxia, i.e. the presentence of hypoxic area 
under a threshold (varied from 50% to 25% sO2) over the total 
tumor area, also increased during tumor progression (Figure 
4c).  Following the in-vivo measurements we harvested the 
tumor tissue and related the non-invasive eMSOT findings to 
the histological assessment of tumor hypoxia (see 
Supplementary Note 6). Tumor tissue was stained by 
Hoechst 33342 22 (indicating perfusion) and Pimonidazole 23 
(indicating cell hypoxia). The results indicated close 
correspondence between the hypoxic areas detected by 
eMSOT using hemoglobin as a hypoxia sensor (Figure 4b) 
and the histology slices (Figure 4d). We found that eMSOT 
could not only quantitatively distinguish between high and 
low hypoxia levels in the tumors, but the spatial sO2 maps 
further presented congruence with the spatial appearance of 
hypoxia spread and reduced perfusion seen in the histology 
slices (Figure 4e-g). A quantitative congruence analysis is 
shown in Supplementary Note 6. Finally, clear differences 
were also observed between the hypoxic tumor and healthy 
tissue response to an O2 breathing challenge (Figure 4h; 
Supplementary Figure 8), with areas in the core of the tumor 
presenting a limited response to such external stimuli, likely 
due to the presence of non-functional vasculature. 
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Figure 4. eMSOT measurements of tissue blood oxygenation in tumor. (a-b) sO2 maps of a 4T1 tumor implanted in the mammary pad at 
day 6 (a) and day 10 (b) after cell inoculation. Dashed lines present a segmentation of the tumor area. Scale bar 1cm. (c) Bar-plot presenting 
the percentage of the total tumor area containing sO2 values lower than a specific sO2 threshold (x axis). Blue bars correspond to the tumor 
imaged at day 6 and red bars correspond to the tumor imaged at day 10, presented in (a, b). (d) Merged Hoechst 33342 and Pimonidazole 
staining of the tumor presented in (b). Scale bar, 2mm.  (e-g) Examples of a highly perfused (upper row) and low perfused (lower row) tumor 
analysed with eMSOT for sO2 estimation (e), Hoechst 33342 staining (f), and merged with Pimonidazole staining (g). Hoechst staining 
presented lower intensity at tumors and tumor areas presenting low sO2 values, as measured by eMSOT.  Scale bar, 2mm. (h) sO2 map of a 
tumor under an O2–CO2 challenge. The computed sO2 values and the eMSOT spectral fit of points 1 and 2 (arrows) are presented in (h right) 
for the three breathing conditions. Scale bar 1cm. 
 
DISCUSSION 
Spectral corruption has so far limited the potential of 
optical and optoacoustic methods to offer accurate, 
quantitative assessment of blood oxygen saturation deep inside 
tissues. Conventional computational methods in optical 
imaging propose to invert a light transport operator to recover 
tissue optical properties (absorption and scattering) 12; then use 
these properties for calculating tissue physiological 
parameters. However, the complexity and ill-posed nature of 
the inversion problem has not allowed so far accurate, high-
resolution sO2 imaging. We discovered a new principle that 
describes the spectral features of light fluence as a 
combination of spectral base functions. Using this principle, 
we formulated the sO2 quantification problem as a non-linear 
spectral unmixing problem that does not require knowledge of 
tissue optical properties.  Effectively, eMSOT converts sO2 
imaging from a problem that is spatially dependent on light 
propagation and optical properties, as common in traditional 
optical methods, to a problem solved in the spectral domain. 
Therefore, sO2 can be directly quantified without estimating 
tissue optical properties.  
eMSOT requires theoretically at least 5 excitation 
wavelengths for resolving spectral domain parameters and the 
relative oxygenated and deoxygenated hemoglobin 
concentrations. We hereby utilized 21 wavelengths for 
ensuring high accuracy. The recent evolution of video-rate 
MSOT imaging systems, based on fast tuning optical 
parametric oscillator lasers24 allows the practical 
implementation of the method. Modern MSOT systems offer 5 
wavelength scans at 20Hz or better. Therefore eMSOT is a 
technology that optimally interfaces to a new generation of 
fast and handheld spectral optoacoustic systems 25. 
The method developed demonstrated quantitative, non-
invasive blood oxygenation images in phantoms and tissues 
in-vivo (muscle and tumor) in high-resolution, showing good 
correlation with the expected physiological state or the 
histologically observed spatial distribution of perfusion and 
hypoxia. eMSOT measures blood oxygenation. We 
hypothesized that a correlation exists to tissue oxygenation 
measurements by assuming a wide presence of hemoglobin in 
tissues. We demonstrated congruence (Supplementary Note 
6) between traditional invasive histological assays resolving 
tissue hypoxia and eMSOT analysis. Importantly, not only 
average values are resolved, but there is a close spatial 
correspondence between hypoxia patterns resolved by eMSOT 
non-invasively and histological analysis (Figure 4, 
Supplementary Figure 7).  
High-resolution non-invasive imaging of blood 
oxygenation across entire tissues and tumors offers novel 
abilities in studying physiological and pathological conditions. 
This goal has been pursued for decades with near-infrared 
methods, but the strong effects of photon scattering and 
photon diffusion on the signals detected limited the imaging 
resolution and impeded accurate quantification8. Optoacoustic 
imaging improves the resolution achieved, over diffuse optical 
imaging methods but its sO2 estimation accuracy has been 
limited so far by depth-dependent fluence attenuation and 
spectral corruption effects. We showed that conventional 
spectral optoacoustic methods employing linear unmixing can 
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significantly misestimate blood saturation values in several 
controlled measurements, including simulations and animal 
measurements. eMSOT was tested on a vast data-set 
consisting of >2000 tissue simulations and was consistently 
found to provide from a comparable to substantially better sO2 
estimation accuracy over linear unmixing. (Supplemental 
Note 3). The large number of simulations was necessary to 
validate eMSOT, which presents a non-convex optimization 
problem. eMSOT was further tested on tissue mimicking 
blood phantoms (Supplemental Note 4) and controlled in-
vivo experiments (Figure 2, Supplemental Note 5). In all 
cases tested, eMSOT offered from comparable to significantly 
more accurate performance over conventional spectral 
optoacoustic methods. 
A particular challenge in this study was the confirmation 
of the eMSOT values obtained in-vivo. Polarography 
measurements are invasive, disrupt the local 
microenvironment and do not allow to recover spatial 
information. Nuclear methods using tracers are not well suited 
for longitudinal studies and utilize tracers which need to 
distribute in hypoxia areas i.e. areas with problematic supply. 
Therefore the results may not directly compare to eMSOT, 
even though such study is planned as a next step. BOLD MRI 
only indirectly resolves the effects of deoxygenated 
hemoglobin but cannot observe oxygenated hemoglobin. For 
this reason, we selected to utilize traditional histology 
methods, using cryoslicing, which allows to maintain spatial 
orientation so that eMSOT and histological results could be 
compared not only in terms of quantity but also in regard to 
the spatial appearance.  
eMSOT offers a novel solution to a fundamental challenge 
in optical and optoacoustic imaging. In the absence of other 
reliable methods that can image blood oxygenation, it may be 
that eMSOT becomes the gold standard method in blood and 
tissue oxygenation studies. Its congruence with tissue hypoxia 
may also allow a broad application in tissue and cancer 
hypoxia studies. Nevertheless eMSOT performs optimally 
when applied on well-reconstructed parts of optoacoustic 
images (Supplementary Note 5). For this reason, it was 
selectively applied herein to the part of the image that is 
within the optimal sensitivity field of the detector employed. 
An eMSOT advantage is that it is insensitive to scaling factors 
such as the Grüneisen coefficient or the spatial sensitivity field 
of the imaging system (Methods).  However, due to its scale 
invariance eMSOT only allows for quantifying blood sO2 and 
not absolute blood volume, a goal that will be interrogated in 
future studies. Next steps further include the eMSOT 
validation with a larger pool of tissue physiology 
interrogations spanning from cancer, cardiovascular and 
diabetes research, relation of physiological phenotypes to 
metabolic and “-omic” outputs and in clinical application. 
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METHODS 
Animal preparation and handling. All procedures 
involving animal experiments were approved by the 
Government of Upper Bavaria. For the preparation of 
orthotopic 4T1 tumor models, 8 week old adult female 
athymic Nude-Foxn1 mice (Harlan, Germany) were 
orthotopically inoculated in the mammary pad with cell 
suspensions (0.5 million 4T1 cells (CRL-2539). Animals 
(n=8) were imaged in-vivo using MSOT after the tumors 
reached a suitable size. All imaging procedures were 
performed under anesthesia using 1.8% Isoflurane. In the O2 
challenge experiment, the mouse was initially breathing 100% 
O2 and in the following medical air (20% O2). During the O2 
Challenge, the mice were stabilized for a period of 10 minutes 
under each breathing condition before MSOT acquisition. For 
controlled mouse measurements (n=4), MSOT acquisition was 
performed on mice under gas anesthesia and breathing 100% 
O2 or 20% O2 by rectally inserting a capillary tube containing 
pig blood at 100% or 0% sO2 oxygenation levels. Mice were 
sacrificed during MSOT imaging with an overdose of CO2 or 
after MSOT acquisition by a Ketamine/Xylazine overdose. In 
the following the mice were stored at -80°C for further 
analysis.   
4T1 cell line was acquired from ATCC (ATCC-CRL-
2539, #5068892). The cells were authenticated by the ACTT 
by several analysis tests: Post-Freeze viability, Morphology, 
Mycoplasma contamination, post freeze cell growth, 
interspecies Determination; bacteria & fungal contamination. 
Additional mycoplasma contamination tests were also 
performed. For the animal studies no randomization, blinding 
or statistical methods were performed. 
MSOT. Optoacoustic imaging was performed using a 
real-time whole body mouse imaging MSOT In Vision 256-
TF (iThera-Medical GmbH, Munich, Germany). The system 
utilizes a cylindrically focused 256-element transducer array at 
5MHz central frequency covering an angle of 270 degrees. 
The system acquires cross-sectional (transverse) images 
through the animal. The animals are placed onto a thin clear 
polyethylene membrane. The membrane separates the animals 
from a water bath, which is maintained at 34°C and is used for 
acoustic coupling and maintaining animal temperature while 
imaging. Image acquisition speed is at 10Hz26. Imaging was 
performed at 21 wavelengths from 700 nm to 900 nm with a 
step size of 10 nm and at 20 consecutive slices with a step size 
of 0.5 mm. Image reconstruction was performed using a 
model-based inversion algorithm 27 28 with a non-negativity 
constraint imposed during inversion and with Tikhonov 
regularization.  
eMSOT method  and sO2 maps. All optoacoustic 
images P(r,λ) obtained over wavelength λ were calibrated to 
correct for the intensity of laser power per pulse, and for the 
absorption of water surrounding the tissue. With HbO2 and Hb 
being the main tissue absorbers in the near-infrared, 
multispectral optoacoustic images can be related to the 
concentrations of oxy- and deoxy-hemoglobin through Eq. (2).   
2 2 2
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( , ) ( ) || ( ) || ( ( ) ( ) ( ) ( )).
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                        (2) 
 
In Eq. (2), C(r) is a spatially varying scaling factor 
corresponding to the effects of the system’s spatial sensitivity 
field and the Grüneisen coefficient, εHbO2(λ) and εHb(λ) are the 
wavelength dependent molar extinction coefficients of 
oxygenated and deoxygenated hemoglobin, while cHbO2(r) and 
cHb(r) the associated concentrations at a position r. ||Φ(r)||2 is 
the norm of the light fluence across all wavelengths at a 
position r, while Φ′(r,λ) = Φ(r,λ)/||Φ(r)||2 is the normalized 
wavelength dependence of light fluence at a specific position 
(i.e. normalized spectrum of light fluence). 
The space-only dependent factors C(r) and ||Φ(r)||2 do not 
affect the estimation of blood sO2 (Eq. (3)) which is calculated 
as a ratio once the relative concentrations of HbO2 and Hb are 
known (we define c′HbO2(r) = C′(r) · cHbO2(r)  and c′Hb(r)=C′(r) 
· cHb(r), respectively, where C′(r) is a common, space-only 
dependent scaling factor): 
 
2
2
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HbO
HbO Hb
c
sO
c c

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r
r
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For the accurate quantitative extraction of the relative 
values of c′HbO2(r) and c′Hb(r), accounting for, or estimating 
the wavelength dependence of the light fluence Φ′(r,λ) is 
further required.  
The Eigenspectra Model for Light Fluence. eMSOT is 
based on the observation that the spectral patterns of light 
fluence present in tissue can be modeled as an affine function 
of only a few base spectra, independently of tissue depth and 
the specific distribution of optical properties of the tissue 
imaged. This hypothesis stems from the notion that the 
spectrum of light fluence is the result of the cumulative light 
absorption by hemoglobin; thus the spectrum of light fluence 
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will always be related to the spectra of hemoglobin in a 
complex non-linear manner. This complex relation can be 
linearized using a data-driven approach, i.e. through the 
application of Principal Component Analysis (PCA) on a 
selected set of light fluence spectra. 
The wavelength dependence of the light fluence was herein 
modeled as a superposition of a mean fluence spectrum ΦΜ(λ) 
and a linear combination of a number of light fluence 
Eigenspectra Φi(λ). This model was derived by applying PCA 
on a training dataset comprised of a set of light fluence 
spectral patterns. Briefly, a training dataset was formed 
through the creation of multispectral light fluence simulations 
using the 1-D analytical solution of diffusion approximation 
for infinite media. A set of light fluence spectral patterns 
Φz,ox(λ)  were computed for high physiological tissue optical 
properties (μα=0.3 cm-1, μs′=10 cm-1), tissue depths ranging 
from z=0 to z=1 cm with a step size of 0.143 mm (70 discrete 
depths in total) and for  21 different uniform background 
tissue oxygenations (ox ∊ [0%, 5%, 10%, …, 100%]). The so 
computed set of light fluence spectra Φz,ox(λ) was normalized 
(Φ’z,ox(λ) = Φz,ox(λ)/||Φz,ox||2) and used in the following as 
training data in the context of PCA in order to create an affine, 
3-dimensional model consisting of a mean fluence spectrum 
ΦΜ(λ) and three Eigenspectra Φi(λ). PCA was used for 
offering a minimum square error property in capturing the 
spectral variability of light fluence in a linear manner. Three 
components were selected for providing a relatively simple 
model while also offering a small model error with respect to 
the training data-set (Figure 1e). The wavelength dependence 
of the light fluence Φ′(r,λ) at any arbitrary tissue position r 
can thus be modeled as a superposition of the mean fluence 
spectrum and three fluence Eigenspectra multiplied by 
appropriate scalar parameters m1, m2, and m3, (hereby referred 
to as Eigenfluence parameters) as per Eq. (4): 
 
1 1 2 2 3 3'( , ) ( ) ( ) ( ) ( )m m m           r           (4) 
 
The so created 3-dimensional affine forward model of the 
wavelength dependence of light fluence was tested with regard 
to light fluence spectral patterns produced in completely 
heterogeneous media with varying and randomly distributed 
optical properties and oxygenation values and demonstrated 
high accuracy (Supplementary Fig. 1). The forward model 
was further tested through in-vivo and ex-vivo light fluence 
measurements, obtained from controlled experiments 
(Supplementary Fig. 2).  
Through simulations, it was observed that the values of the 
m2 Eigenfluence parameter relate primarily to tissue depth and 
the average tissue optical properties. This trend was observed 
both in the case of tissue simulations with uniform optical 
properties (Figure 1g) as well as in complex and randomly 
created tissue simulations described in Supplementary Note 
1, 3. Conversely, the values of the Eigenfluence parameters m1 
and m3 relate both to tissue depth as well as to tissue 
background oxygenation. Specifically both m1 and m3 present 
a trend of increasing absolute values with depth and a sign that 
relates to background tissue oxygenation. These observations 
were confirmed with in-vivo and ex-vivo light fluence 
measurement experiments (Supplementary Note 1).  
 
Model Inversion. Using the Eigenspectra model of light 
fluence, the blood sO2 quantification problem at a position r 
formulates as the problem of estimating c′HbO2(r) and c′Hb(r) 
by minimizing f(r; m1(r), m2(r), m3(r) c′HbO2(r), c′Hb(r)), for 
brevity noted f(r), defined according to Eq, (5): 
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2 2
1 2
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i
f P m c c      
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                                  (5)
   
The solution for the 5 unknowns (namely the 3 light fluence 
model parameters, 1...3( )m r  and the relative blood 
concentrations c′HbO2(r) and c′Hb(r)) can be obtained using a 
non-linear optimization algorithm and at least 5 excitation 
wavelengths. The relative blood concentrations c′HbO2(r) and 
c′Hb(r) are proportional to the actual ones (cHbO2(r) and cHb(r)) 
with regard to a common scaling factor. However, as stated 
before, this fact does not affect the computation of sO2.  
The minimization problem defined by Eq. (5) is ill-posed 
and may converge to a wrong solution unless properly 
constrained. For achieving inversion stability and accurate sO2 
estimation results, the cost function f of Eq. (5) is 
simultaneously minimized in a set of grid points placed in the 
image domain (Figure 1i), where three independent 
constraints are further imposed to the Eigenfluence 
parameters. These constraints correspond to the relation of the 
Eigenfluence parameters between neighbor grid points and to 
the allowed search space for the Eigenfluence parameters:  
(i) Since the values of the second Eigenfluence parameter 
m2 present a consistent trend of reduction with tissue depth 
observed both in the case of uniform tissue simulations (see 
Fig. 1g) as well as in simulations with random structures, m2 
is constrained to obtain smaller values in the case of grid 
points placed deeper into tissue.  
(ii) Since the light fluence is bound to vary smoothly in 
space due to the nature of diffuse light propagation, large 
variations of the Eigenfluence parameters m1, and m3 between 
neighbor pixels are penalized. This is achieved through the 
incorporation of appropriate Lagrange multipliers λi to the cost 
function for constraining the variation of the model parameters 
(Eq. (6)). The values of the Lagrange multipliers were selected 
using cross-validation on simulated data-sets (Supplementary 
Note 2). 
(iii) Since the values of m1 and m3 are strongly dependent 
on background tissue oxygenation, an initial less accurate 
estimation of tissue sO2 can be effectively used to reduce the 
total search-space to a constrained relevant sub-space. The 
limits of search space for the Eigenfluence parameters m1 and 
m3 corresponding to each grid point are identified in a 
preprocessing step as analytically described in 
Supplementary Note 2.  
Assuming a circular grid of P arcs and L radial lines (see 
Suppl. Fig. 3) with a total of P x L points rp,l, and let the 
vector mi =[mi(r1,1), mi(r1,2), …, mi(r1,L), mi(r2,1), …, 
mi(rp,l),…,mi(rP,L)] correspond to the values of the light 
fluence parameter i (i=1…3) over all such points, the new 
inverse problem is defined as the minimization of cost 
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function fgrid defined in Eq. (6) under the constraints defined in 
Eq. (7). 
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In Eq. (6), W is the weighted connectivity matrix 
corresponding to grid of points assumed (Supplementary 
Note 2). Each matrix element corresponds to a pair of grid 
points rp1,l1 rp2,l2  and is zero if the points are not directly 
connected or inverse proportional to their distance (w(rp1,l1 
rp2,l2) = 1/|| rp1,l1 - rp2,l2 ||2) if the points are connected. The 
inverse problem defined by Eq. (6), (7) was hereby solved 
through the utilization of sequential quadratic programming 
algorithm of MATLAB toolbox.  
Fluence correction and sO2 quantification. The 
minimization of cost function fgrid (Eq. (6)) under the 
constraints of Eq. (7) yields an estimate of mi(r) for each 
Eigenfluence parameter i and each grid point r. The 
Eigenfluence parameters in the convex hull of the grid are in 
the following estimated by means of cubic interpolation. We 
note that due to the nature of diffuse light propagation the 
Eigenfluence parameters are expected to vary smoothly in 
tissue and thus their interpolation is not expected to introduce 
large errors in the result (see Supplementary Note 3). The 
wavelength dependence of light fluence is computed for each 
pixel within the convex hull of the grid as in Φ′(r,λ)  = ΦM(λ) 
+ m1(r)Φ1(λ) + m2(r)Φ2(λ) + m3(r)Φ3(λ), where Φi(λ) is the ith 
fluence Eigenspectrum. Finally, a spectrally-corrected eMSOT 
image is obtained after diving the original image P(r,λ) with 
the normalized wavelength dependent light fluence Φ′(r,λ) at 
each position r and wavelength λ, i.e. PeMSOT(r,λ) = P(r,λ)/ 
Φ′(r,λ). Blood sO2 is computed for each pixel of PeMSOT(r,λ) 
image independently through nonnegative constrained least 
squares fitting with the spectra of oxygenated and 
deoxygenated hemoglobin. Thus the eMSOT blood sO2 maps 
retain the original resolution of the MSOT imaging system. 
We note that both the Eigenspectra model and the inversion 
scheme were hereby optimized for the application of small 
animal imaging. The Eigenspectra model was trained for a 
maximum depth of 1 cm and the inversion scheme was 
designed with respect to the same tissue depth and optical 
properties within the physiological range (Supplementary 
Note 2, 3). 
Blood Phantom Preparation. For validating the 
accuracy of eMSOT in quantifying blood oxygenation in deep 
tissue, we prepared tissue mimicking phantoms, containing 
blood at known oxygenations levels. Specifically, for 
simulating tissue background, 2cm –diameter cylindrical solid 
phantoms were created by using 1.5% Agarose Type I, Sigma-
Aldrich (solidifying in <37o), 2% intralipid and 3-5% freshly 
extracted pig blood diluted in NaCl. Different blood 
oxygenation levels were achieved by diluting oxygen in whole 
blood (oxygenation process) or by mixing the blood with 
different amounts of Sodium Dithionite (Na2O4S2) 
(deoxygenation process) 29. The levels blood oxygenation 
were monitored using a Bloodgas Analyzer (Eschweiler Gmbh 
& Co. KG, Kiel Germany). 
Cryoslicing color imaging and H&E staining of 
tumor tissues.  After MSOT acquisition, a subset of the mice 
bearing 4T1 mammarian tumors (n=4) were sacrificed and 
examined for tumor and tissue anatomy. Mice were embedded 
in an optimal cutting temperature compound (Sakura Finetek 
Europe BV, Zoeterwonde, NL) and frozen at -80°C. In the 
following the mice were sliced at an orientation similar to the 
MSOT imaging and color photographs were recorded. The 
cryoslicing imaging system is based on a cryotome (CM 1950, 
Leica Microsystems, Wetzlar, Germany), fitted with CCD-
based detection camera. During this process, 10 µm slices 
throughout the whole tumor volume were collected for further 
histological analysis. 
Several slides per tumor were subjected to H&E staining 
and imaging. The slides containing 10µm cryo-sections were 
first pre-fixed in 4% PFA (Santa Cruz Biotechnology Inc., 
Dallas, Texas, USA). Then, they were rinsed with distilled 
water and incubated 30 seconds with Haemotoxylin acide by 
Meyer (Carl Roth, Karlsruhe, Germany) to stain the cell 
nuclei. The slides were then rinsed in tap water again before 
incubation for 1 second in Eosin G (Carl Roth, Karlsruhe, 
Germany) to stain cellular cytoplasm. After rinsing in distilled 
water, the slides were dehydrated in 70%, 94% and 100% 
ethanol and incubated for 5 minutes in Xylene  (Carl Roth, 
Karlsruhe, Germany) before being cover slipped with 
Rotimount  (Carl Roth, Karlsruhe, Germany) cover media. 
Representative slides were observed using Zeiss Axio Imager 
M2 microscope with AxioCam 105 Color, and pictures were 
then processed using a motorized stitching Zen Imaging 
Software (Carl Zeiss Microscopes GmbH, Jena, Germany).     
Pimonidazole Staining of tumor tissues. A subset 
of the tumor-bearing mice (n=4) was examined for functional 
characteristics of the tumors by Pimonidazole histological 
staining. The hypoxia marker Pimonidazole (Hypoxyprobe, 
catalog #HP6-100 kit, Burlington, MA, USA) was injected i.p. 
at 100 mg/kg body weight in a volume of 0.1 ml saline ≈1.5h 
before tumor excision, and the perfusion marker Hoechst 
33342 (Sigma, Deisenhofen, Germany) was administered i.v. 
at 15 mg/kg body weight in a volume of 0.1 ml saline 1min 
before the tumor-bearing mice were sacrificed. The tumors 
were excised immediately after the animals were sacrificed. 
The orientation of the tumors with respect to the mouse body 
was retained. 8 µm cryosections were sliced throughout the 
tumor. The cryosections were fixed in cold (4°C) acetone, air 
dried and rehydrated in PBS before staining. Pimonidazole 
was stained with the FITC-labelled anti-Pimonidazole 
antibody (Hypoxyprobe, Burlington, MA, USA) diluted 1:50 
in primary antibody diluent (PAD, Serotec, Oxford, U.K.) by 
incubating for 1h at 37°C in the dark.  
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SUPPLEMENTAL MATERIAL 
Supplementary Note 1: Numerical and experimental 
validation of the Eigenspectra model of light fluence 
(forward model validation). 
For validating the accuracy of the Eigenspectra model for 
light fluence (ΦM(λ), Φ1(λ), Φ2(λ), Φ3(λ))  over light fluence 
spectra created in arbitrary tissues, we created simulations of 
the absorbed energy density of arbitrary tissues at different 
wavelengths (700 nm to 900 nm with a step of 10 nm), using 
light propagation models. Assuming a circular structure of 1 
cm radius, random maps of optical absorption (μα(r)) and 
reduced scattering coefficient (μs′(r)) were formed 
(Supplementary Fig. 1a and b, respectively), the values of 
which follow a Gaussian distribution (μα∊N( μαmean, μαstd)  
where μαmean ∈[0.07, 0.3] cm-1 and μαstd=0.1 cm-1, μs′ ∊ 
N(μsmean, μsstd) ) where μsmean∈[7, 11] cm-1 and μsstd=3 cm-1).  
The so created absorption maps (μα(r)) correspond to tissue 
absorption at an excitation wavelength of 800 nm (isosbestic 
point of hemoglobin). The absorption maps for different 
excitation wavelengths are computed based on the one at 800 
nm and the absorption spectra of oxy- and deoxy-hemoglobin. 
The relative amount of oxy- versus deoxy-hemoglobin at each 
position r is defined by a random map of tissue blood 
oxygenation (Supplementary Fig. 1c). Different blood sO2 
maps were simulated (one example presented in 
Supplementary Fig. 1c) with spatially varying random 
oxygenation values, and with an average tissue oxygenation 
varying from ~10% to 90% and a standard deviation of 30%. 
The multispectral absorption and scattering maps were 
employed in a 2D finite-element-method (FEM) solution of 
the diffusion equation (DE)1 to simulate multispectral 
optoacoustic data-sets (i.e. multi-wavelength absorbed energy 
density) of tissue with arbitrary structure, optical properties 
and oxygenation. One such example is shown in 
Supplementary Figure 1d for a single wavelength. From 
these datasets, the normalized wavelength dependent light 
fluence Φ′(r,λ)=Φ(r,λ)/||Φ(r)||2 was calculated for each 
position r in the image. The residual value obtained after 
comparing the simulated fluence spectra Φ′(r) to their 
approximation using the basis functions of the Eigenspectra 
model (Φ′Model(r)) was computed (res =||Φ′(r)- 
Φ′Model(r)||2/||Φ′(r)||2) for each pixel in the image r and 
statistics of this value are presented in Supplementary Figure 
1e. Statistics correspond to all pixels of 21 simulations per 
mean oxygenation, corresponding to different mean optical 
absorption and scattering (231 simulations in total). 
Supplementary Figure 1f further plots the error of the 
forward model in the sO2 estimation (i.e. the error propagated 
in sO2 estimation due to the approximation of Φ′(r,λ) with 
Φ′Model(r,λ)).  
The Eigenspectra forward model was tested with 231 
simulations of high (Suppl. Fig. 1a-c) and 231 simulations of 
low spatial variation of optical properties (Suppl. Fig. 1g) and 
oxygenation. Moreover the forward model was tested in 
simulations of blob-like features (representing organs) and 
vessel-like structures (Suppl. Fig. 1h). In this case, the blob-
like structures correspond to μα = 0.3 cm-1, the background to 
μα = 0.1 cm-1 and the vessel like structures to μα = 5.4 cm-1 and 
μs′ = 16 cm-1. The μs′ and sO2 maps corresponding to the 
background followed a random distribution as previously 
described and the sO2 of the vessel-like structure was retained 
uniform and 25% higher than the mean oxygenation of the 
background.  Statistics on the fitting residual of the forward 
model on the simulations of Supplementary Figure 1a, g, h 
are presented in Supplementary Figure 1e, j, k, respectively. 
We observed a small error in the forward model independently 
of tissue structure and the variations of optical properties and 
tissue oxygenation.  
To assess the potential influence of parameters not included 
in the model such as the absorption of melanin and the 
wavelength dependence of scattering we further created 
simulations containing a strongly absorbing melanin 
component at the tissue surface (μα = 2.5 cm-1) and an 
exponentially decaying scattering coefficient (μs′= 
18.9(λ/500)-0.6 cm-1) that corresponds to whole blood 
measurements2; an example presented in Supplementary 
Figure 1i. The assumed optical properties were again 
following a normal distribution with μα ∊ N(μαmean, μαstd) where 
μαmean ∈[0.07, 0.3] cm-1 and μαstd=0.1 cm-1, μs′ ∊ N(μsmean, μsstd) 
) where μsmean ∈[7, 11] and μsstd =3 cm-1 (21 simulations per 
mean oxygenation, 231 simulations in total). Similar to the 
absorption maps, the so created scattering maps μs′(r) 
correspond to tissue scattering at an excitation wavelength of 
800 nm. The scattering maps for different excitation 
wavelengths are computed based on the one at 800 nm and the 
exponentially decaying curve of the scattering coefficient.  In 
this case the fitting residual of the forward model is increased 
(Suppl. Fig. 1 l) but is still preserved in relatively low levels 
indicating that the model retains accuracy despite the 
simplifying assumptions in its creation.   
The accuracy of the forward model in the ballistic regime 
was tested using Monte Carlo simulations3 of multi-layered 
tissue (Suppl. Fig. 1 m). Four different tissue layers were 
assumed with different oxygenation levels and optical 
properties. In this case the fitting residual of the forward 
model is similar to the one when using the diffusion 
approximation: 0.61±0.22%.  
The graphs indicate a small model error, supporting the 
hypothesis that a simple affine model with only three 
Eigenspectra can capture the spectral variability of Φ′(r,λ) in 
complex tissue structures, independently of the distribution of 
the optical properties. We hereby note that the error in 
oxygenation depicted in Supplementary Figure 1f is just 
indicative of the model accuracy (error of the forward model) 
and does not relate to the actual blood sO2 estimates that can 
be obtained through this procedure by solving the inverse 
problem (estimation error of the inverse problem). 
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Supplementary Figure 1.  Numerical validation of the 
Eigenspectra model of light fluence in tissue simulations of 
arbitrary structures. (a,b) Random spatial map of (a) μα at 800 nm 
and (b) μs′ with random, normally distributed values. (c) Random 
spatial map of sO2. (d) Example of multi-wavelength absorbed 
energy density simulation, at wavelength 800 nm, created using the 
FEM DE light propagation model. (e) Statistics (mean and standard 
deviation - errorbar) on the fitting residual of the Eigenspectra model 
computed from all pixels of each simulated multispectral dataset. (f) 
Error propagated to sO2 estimation due to the fluence approximation 
using the Eigenspectra model. (g-i) Tissue simulations of low spatial 
variation of optical properties (g), partially uniform optical properties 
with highly absorbing vessel like structures (h) and cases of high 
melanin absorption in the tissue surface as well as wavelength 
dependent scattering (i). (j-l) Statistics of the fitting residual of the 
forward model corresponding to g-i, respectively. (m) Monte Carlo 
simulations of the wavelength dependent light fluence (fluence in one 
wavelength is presented) in the ballistic and semi-ballistic regime, 
assuming semi-uniform multi-layered tissue; Layers are highlighted 
with red arrows and their optical properties are summarized in the 
enclosed table.  
 
To experimentally investigate the validity of the 
Eigenspectra model of tissue light fluence we obtained 
measurements from small animals in-vivo and post-mortem. 
We measured the light fluence in tissue by inserting a 
reference chromophore with well characterized spectrum 
within tissue. Specifically, a capillary tube was rectally 
inserted into an anesthetized CD1 mouse and the animal was 
imaged in the lower abdominal area in-vivo using the MSOT 
system. The capillary tube was filled with black India ink, the 
spectrum of which was previously measured in the 
photospectrometer. The animal was imaged in-vivo under 
100% O2 breathing and ex-vivo. These two different 
physiological conditions were employed in order to investigate 
the influence of the average background tissue oxygenation on 
the spectrum of the light fluence. 
The per-wavelength image intensity at the region of the ink 
insertion (i.e. the optoacoustic measured spectrum which 
corresponds to the multiplication of the local absorption with 
the local light fluence) was elementwise divided by the actual 
absorption spectrum of ink. The resulting spectrum after 
division corresponds to the wavelength dependence of the 
local light fluence. The measured light fluence spectrum 
computed in this way was fitted to the Eigenspectra model 
and the two curves and the fitting residual are presented in 
Supplementary Figure 2.  
Supplementary Figure 2a presents a single wavelength 
optoacoustic image of the mouse in the abdominal area. The 
area where the light fluence is measured is indicated with a red 
circle. Supplementary Figure 2b presents the spectrum of the 
experimentally measured light fluence (black curves) and the 
fitting result using the Eigenspectra model in the case of in-
vivo (blue curve) and post-mortem imaging (red curve). The 
low fitting residuals indicate good agreement of the model 
with experimental reality. Supplementary Figure 2c presents 
the decomposition of the two fitted light fluence spectra as a 
linear combination of the mean fluence spectrum and the three 
Eigenspectra. While the first and the third Eigenspectra 
components change dramatically with respect to the two 
different tissue oxygenation states, the second component that 
corresponds to tissue depth remains relatively unchanged. 
Moreover the values of the m1 parameter obtained after fitting 
were positive in the post-mortem case and negative in the in 
vivo case, an observation that is in accordance with the 
dependence of m1 on background tissue oxygenation as 
presented in Figure 1f. This observation was confirmed by 
performing the same experiment in 2 more animals. Overall, 
the low fitting residual even in the case of experimental data 
obtained in-vivo indicates good agreement between theory and 
experimental reality.  
 
 
Supplementary Figure 2. Validation of the Eigenspectra model in 
the case of tissue data obtained in-vivo. (a) MSOT image (one 
wavelength presented) of a CD1 mouse imaged in the abdominal 
region with a capillary tube containing a reference absorber inserted 
in the lower abdominal area (red circle). Scale bar, 1 cm. (b) 
Comparison of the measured spectrum of light fluence in the area of 
absorber insertion (black curves) with the fitted result using the 3-
dimensional Eigenspectra model in the case of in-vivo imaging (blue 
curve) and post-mortem imaging (red curve). (c) The two light 
fluence spectra can be decomposed in a linear combination of spectra 
ΦM(λ), m1Φ1(λ), m2Φ2(λ) and m3Φ3(λ). 
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Supplementary Note 2: Constrained inversion 
The spatial characteristics of light fluence were exploited for 
overcoming the ill-posed nature of the optimization problem 
defined by Eq. (5). In contrary to tissue absorption which can 
vary arbitrarily, the light fluence is bound to vary smoothly in 
space due to the nature of diffuse light propagation. In the 
context of the Eigenspectra model inversion, such a priori 
information can be incorporated by attempting simultaneous 
inversion on a grid of points in the image domain (an example 
of such a grid is shown in Suppl. Fig. 3a), and penalizing 
large variations of the Eigenfluence parameters between 
neighbor pixels. A matrix W representing a weighted non-
directed graph (Supplementary Figure 3b) is defined based 
on the assumed grid, where neighbor grid points are connected 
with weighted vertexes. We penalize large spatial variations of 
light fluence by incorporating the norm of the variation of the 
Eigenfluence parameters m1 and m3 in the minimization 
function using Lagrange multipliers: Assuming a circular grid 
of P arcs and L radial lines (Supplementary Figure 3b), with 
a total of P x L points rp,l, and let the vector mi =[mi(r1,1), 
mi(r1,2), …, mi(r1,L), mi(r2,1), …, mi(rp,l),…,mi(rP,L)] 
correspond to the values of the Eigenfluence parameter i 
(i=1…3) over all such points, the new cost function fgrid is 
defined by Eq. (2.1): 
 
1 2 3 3 2( ) || || || || ,grid i
i
f f     1r Wm Wm           (2.1) 
 
where f is the cost function defined in Eq. (5) and W is the 
weighted connectivity matrix corresponding to grid of points 
assumed. Each matrix element corresponds to a pair of grid 
points rp1,l1 rp2,l2  and is zero if the points are not directly 
connected or inverse proportional to their distance (w(rp1,l1 
rp2,l2) = 1/|| rp1,l1 -rp2,l2 ||2) if the points are connected.  
The values of the Lagrange multipliers λ1 and λ3 were 
selected using cross-validation on simulated data-sets with 
finely granulated structures (Supplementary Figure 1a-c). 
We did not observe high sensitivity of the result obtained to 
small changes of the Lagrange multipliers. The same values 
for the Lagrange multipliers were used for all simulated and 
experimental data presented in the work.   
An alternative spatial fluence constraint is applied in the 
case of the second Eigenfluence parameter m2. Through 
simulations of uniform optical properties as well as 
simulations with randomly varying optical properties it was 
observed that the values of m2 are strongly and consistently 
associated with tissue depth, obtaining lower values in deeper 
tissue areas. Through the definition of an additional directed 
graph based on the assumed gird (Supplementary Figure 3c) 
the value of m2 at a certain grid point was enforced to obtain 
larger values than the ones of its direct neighbors placed 
deeper in tissue:  
 
2 1, 2 , 2 1, 1 2 , 2 1, 1 2 ,( ) ( ), ( ) ( ), ( ) ( ), , ,p l p l p l p l p l p lm m m m m m p l       r r r r r r
                       (2.2) 
 
For further enhancing the inversion stability, additional 
constraints were imposed to the Eigenfluence parameters that 
relate to both depth and background tissue oxygenation (i.e. 
m1 and m3) based on a first approximate estimate of tissue 
blood oxygenation. By performing linear spectral unmixing on 
the raw multispectral optoacoustic images P(r,λ) a first 
estimation map of blood sO2 levels can be obtained. It is noted 
that this sO2 map is incrementally erroneous with tissue depth, 
however it can serve as a first approximation for constraining 
the total search-space for m1 and m3 to a more relevant sub-
space. Using the so created sO2 map (Suppl. Figure 3d) and 
by assuming uniform tissue optical properties (i.e. μα= 0.3 cm-
1 at 800 nm and  μs′=10 cm-1) a light fluence map is simulated 
using a FEM of the DA. By fitting the simulated light fluence 
spectra Φ′(r,λ) to the Eigenspectra model, prior estimates of 
all model parameters ḿ1(r), ḿ2(r) and ḿ3(r) can be obtained 
for each grid point r. A map of ḿ1 corresponding to the sO2 
map of Suppl. Figure 3d is presented in Suppl. Figure 3e 
while the values of ḿ1(r) for all positions r in one radial line 
of the gird in Suppl. Figure 3a are presented in Suppl. Figure 
3f (blue line).  
The optimization problem of Eq. (2.1) is solved, with the 
values of m1(r) and m3(r) constrained to lie within a region 
surrounding the initial prior estimate ḿi(r) (blue vertical lines 
in Suppl. Figure 3f): 
 
min max
, ,lim ( ) lim , , 1,3.i i im i   k kr k rr k           (2.3) 
 
The limits of the allowed search space (limi,rkmin, limi,rkmax) 
were selected ad hoc as a function of the prior Eigenfluence 
values ḿi and tissue depth, through the comparison of the 
prior and the real Eigenfluence parameters computed in tissue 
simulations of varying (uniform) optical properties (μα ∊ [0.1-
0.3]cm-1 at 800 nm, μs′=10 cm-1) and all uniform oxygenation 
levels. It is noted that the allowed search space is 
incrementally larger with tissue depth since in deep tissue the 
original sO2 estimates (and thus the Eigenfluence priors) 
usually deviate significantly from the true values. 
Supplementary Figure 3f presents an example of constrained 
inversion corresponding to a radial grid line of the simulation 
of Supplementary Figure 3a: The blue line indicates the 
prior ḿ1(r) across the grid pixels, the blue vertical lines 
indicate the limits of search space, the green line indicates the 
actual m1(r) values of the grid points and the red line the 
estimated ones after nonlinear optimization. The same 
function for computing the limits (limi,rkmin, limi,rkmax) as a 
function of the prior ḿi estimate and tissue depth was used for 
all simulated and experimental data presented in the work.   
We note that this constraint (identified through trends in 
uniform tissue data) may not always be exact in data of 
complex structures of optical properties and oxygenation; thus 
excluding in certain cases the optimal solution from the 
allowed search space. Despite this, the evaluation of 
Supplementary Note 4 indicated that the enforcement of this 
constraint typically leads to a solution close to the optimal one 
even in such cases, while it minimizes the possibility or an 
irrelevant convergence in all cases; sacrificing thus accuracy 
for robustness.  
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Supplementary Figure 3. Incorporation of constraints on the 
values of the Eigenfluence parameters m1, m2 and m3. (a) 
Inversion is performed simultaneously on a grid of points in the 
image domain.  (b) A non-directed weighted graph on the grid of 
points penalizes large variations of the Eigenfluence parameters 
between neighbor points. The penalization is inversely proportional 
to the distance w between the grid points. (c) A directed graph on the 
grid of points enforces a decrease on the values of m2 with depth. (d-
f) An initial approximation of tissue blood oxygenation is obtained 
using nonnegative constrained least squares fitting (d) and used for 
obtaining a prior estimate of m1 (e) and m3 model parameters. These 
prior estimates are used for constraining the total search space. (f) 
Prior ḿ1 estimate (blue line), limits of the search space (blue vertical 
lines), actual m1 values (green line) and m1 values estimated after 
optimization (red line) for a radial line of the grid presented in (a).  
 
Supplementary Note 3: Numerical validation of eMSOT.  
For investigating the ability of eMSOT to obtain accurate 
quantitative estimates of tissue blood oxygenation we 
validated its performance using numerical simulations of 
multi-wavelength absorbed energy density. The absorbed 
energy density simulations were formed as described in 
Supplementary Note 1 using random or semi-random maps 
of absorption, scattering coefficient and blood oxygenation. A 
large validation data-set of more than 2000 different 
simulations was employed. The optical properties and sO2 
maps followed a random spatial variation with different 
structural characteristics ranging from finely granulated to 
smoothly varying structures (Suppl. Fig. 4a) as well as highly 
absorbing vascular structures with an absorption coefficient 
ranging from 1 to 6 times larger than the mean tissue 
background (Suppl. Fig. 4a right low). In each case the mean 
tissue optical properties varied from low to high tissue 
absorption and scattering (Suppl. Fig. 4b) in the physiological 
range (μαmean= 0.07 0.1, 0.15, 0.2, 0.25, 0.3 cm-1 at 800 nm and 
μsmean = 7, 9, 11 cm-1). For each combination of μαmean, μsmean, 
different random blood sO2 maps were assumed ranging from 
a mean tissue oxygenation of 10% to 90%. Random Gaussian 
noise with energy varying from 2.5% to 4.5% of the original 
energy of the spectra in each pixel was further superimposed. 
Supplementary Figure 4c presents a simulated 
multispectral optoacoustic image (one wavelength presented) 
after incorporating the optical property maps in a FEM 
solution of the diffusion equation. An arc-shaped grid of 50 
points is applied in the upper-left part of the simulation for the 
application of the eMSOT method. The parameters of 
inversion and the constraints employed were the same with the 
ones used for analyzing the in-vivo datasets and are 
analytically described in Methods and Supplementary Note 
2. An example of the original (green) and the noisy spectrum 
(blue) corresponding to a pixel of Suppl. Fig. 4c with 4.5% 
superimposed random noise is visualized in Suppl. Fig. 4d. 
Supplementary Figure 4e-g present the recovered maps of 
the Eigenfluence parameters m1, m2 and m3 after inversion and 
interpolation in the convex hull of the grid. Suppl. Fig. 4h-j 
present the sO2 estimation using nonnegative constrained least 
squares fitting with the spectra of oxy- and deoxy-hemoglobin 
on the original simulation (h), eMSOT sO2 estimation (i), as 
well as the actual simulated sO2 map (j). Supplementary 
Figure 4k presents the corresponding errors in sO2 estimation 
of the eMSOT method (blue points) and linear unmixing (red 
points) in all pixels of the analyzed area, sorted per depth. The 
sO2 estimation error maps in the whole analyzed area were 
used for statistically evaluating the eMSOT performance. 
Upon evaluation of the method on a set of more than 2000 
randomly created simulations, we observe that in the 
physiological range of mean tissue oxygenation between 30% 
and 80% the mean sO2 estimation error ranges from 2.4% to 
3.4% depending on the levels of random noise, while in ~97% 
of the cases the sO2 error did not exceed 10% (Supplementary 
Table 1). We did not observe dramatic performance 
differences between different mean optical properties or 
different structures of the optical properties. We further did 
not observe significant performance degradation with high 
levels of superimposed noise indicating that the inversion 
scheme is rather robust to noise. The largest errors were 
observed in the case of less than 30% mean tissue 
oxygenation. In this case the mean sO2 error was 5% and in 
~97% of the cases the error was less than 15%. The results of 
the statistical evaluation of the method over all simulations 
tested are analytically presented in Supplementary Table 1.  
 Supplementary Figure 4l presents the mean sO2 error of 
linear unmixing and eMSOT corresponding to each simulated 
data-set tested, while Supplementary Figure 4m present the 
histogram of the mean sO2 error corresponding to all 
simulations.  In 88% of all cases tested the eMSOT method 
offered a lower mean estimation error than conventional linear 
unmixing. In the rest 12% of the cases linear unmixing offered 
a better estimation, but the mean sO2 errors were comparable 
and both were lower than 8%.  Finally, Supplementary 
Figure 4n presents a histogram of the relative sO2 error 
yielded by linear unmixing over eMSOT for all simulated 
data-sets tested and for simulated tissue depths>5mm; 
indicating that eMSOT typically offered 3 to 8-fold enhanced 
sO2 estimation accuracy in deep tissue. 
The statistical evaluation of Suppl. Table 1 corresponds to 
the application of a circular grid of an angle step of π/20 rads 
and a radial step of 0.14 cm. The effect of the grid density in 
the sO2 estimation accuracy was further tested through the 
application of different grid densities spanning from 12, 30, 49 
and 108 points in a π/4 disk area; the results are summarized 
in Suppl. Table 2. We observed that the sO2 estimation 
accuracy does not increase dramatically with an increased grid 
density due to the smooth spatial variations of light fluence in 
tissue. 
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Supplementary Figure 4. Numerical validation of eMSOT in simulations of arbitrarily structured tissues. (a) Examples of the assumed 
random maps of optical absorption, optical scattering and sO2 varying from finely granulated to smoothly varying structures and vessel-like 
patters. The combination of these maps was used to simulate the absorbed energy density of complex tissue using a light propagation model. 
(b) The absorbed energy densities were formed with varying mean optical properties simulating weakly to strongly absorbing/scattering tissue. 
(c) Simulated multispectral optoacoustic image (one wavelength presented). A circular grid is employed in the upper left part of the image for 
further analysis using eMSOT. (d) Original (green) and noisy (blue) simulated spectral response stemming from one pixel of (c). (e-g) Maps of 
Eigenfluence parameters m1, m2 and m3, respectively obtained after inversion and interpolation. (h-i) sO2 estimation using linear unmixing (h) 
and eMSOT (i). (j) Actual simulated sO2 map. (k) sO2 estimation error corresponding to all pixels of the analyzed area using conventional 
linear unmixing (red points) and the eMSOT method (blue points), sorted per depth. (l) Mean sO2 error of linear unmixing (red) and eMSOT 
inversion (blue) corresponding to each simulated data-set tested. (m) Histogram of the mean sO2 estimation error corresponding to eMSOT 
(blue) and linear unmixing (red) for all simulated data-sets tested. (n) Histogram of the relative sO2 estimation error of linear unmixing as 
compared to eMSOT for all simulated data-sets tested and simulated tissue depths>5mm.   
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 Physiological range (30%-80% mean sO2) 0%-30% 
mean sO2 
80%-100% 
mean sO2 
Vessel network 
(30%-80% sO2) 
μαmean (cm-1) 
μs mean(cm-1) 
[0.07-0.15] 
[7-11] 
[0.2-0.3] 
[7-11] 
[0.07-0.3] 
[7-11] 
[0.07-0.3] 
[7-11] 
[0.1, 0.2, 0.3] 
[7, 9, 11] 
Noise lvl. 2.5% 4.5% 2.5% 4.5% 2.5% 2.5% 2.5% 2.5% 
Scale       1-3 3-6 
Mean sO2 
error 
2.36% 
(4.54%) 
2.67% 
(4.65%) 
2.82% 
(7.9%) 
3.38% 
(7.9%) 
5.1% 
(15.6%) 
1.85% 
(11%) 
2.45% 
(5.83%) 
2.0% 
(4.4%) 
% of pixels 
<10% error 
98.6% 
(89.4%) 
98.1% 
(89.1%) 
97.1% 
(70.8%) 
95.0% 
(70.4%) 
85.8% 
(38%) 
99.5% 
(56%) 
98.3% 
(81.7%) 
99.1% 
(87.5%) 
% of pixels 
<15% error 
99.8% 
(97.2%) 
99.7% 
(97%) 
99.3% 
(85%) 
98.7% 
(84.8%) 
97% 
(57%) 
99.9% 
(74.9%) 
99.8% 
(93%) 
99.8% 
(96%) 
Supplementary Table 1. Statistics of the eMSOT performance as evaluated on large simulated data-set (red corresponds to 
conventional linear unmixing).  
 
Grid points 12 30 56 108 
Av. computational speed (sec) 1.8 sec 10 sec 52 sec 487 sec 
Mean sO2 error 3.16% 2.74% 2.5% 2.36% 
% of pixels <10% error 95.9% 97.7% 98.1% 98.5% 
Supplementary Table 2. Statistics of the eMSOT performance as a function of grid density. Statistics correspond to 108 simulated data-
sets of μαmean ∊ [0.1 0.3] cm-1, μs mean=10cm-1 and mean sO2 varying between 30%-80%. 
 
 
Supplementary Note 4: Validation of eMSOT with tissue 
mimicking blood phantoms 
Blood phantoms with controlled oxygenation levels were 
created for validating the eMSOT accuracy under 
experimental conditions where gold standard is available. 
Different blood sO2 levels were created by adding different 
amounts of Sodium Dithionite (Na2O4S2)4, a chemical that 
allows for efficient deoxygenation of blood. Control 
experiments indicated that blood solutions in NaCl and 
intralipid could be stably retained at 100% sO2 under no 
Na2O4S2 addition and at 0% under 100 mg/g Na2O4S2 
addition. When Na2O4S2 was added at a concentration of 2-4 
mg/g, blood solutions were initially deoxygenated but would 
gradually change to higher oxygenation levels.   
Different types of cylindrical (diameter 2cm) tissue 
mimicking solid blood phantoms were created consisting of 
3%-5% blood in a solution of NaCl, intralipid (2%) and low 
temperature melting Agarose. Four different states of 
background blood oxygenation were formed though the 
administration of 100 mg/g Na2O4S2 (corresponding to 0% sO2 
background), 3 mg/g Na2O4S2, 4 mg/g Na2O4S2 
(corresponding to an unknown and spatially varying sO2 in 
background) and 0 mg/g Na2O4S2 (corresponding to 100% sO2 
background). A 3mm diameter insertion containing a sealed 
capillary tube filled with 20% blood at 0% sO2 and 100% sO2 
was introduced at a depth of 5-8mm in each solid blood 
phantom. The phantoms were imaged using MSOT and the 
images were analyzed using the eMSOT method and 
conventional linear unmixing.  
Supplementary Fig. 5a-b present the application of the 
eMSOT method in the case of a uniform phantom of 0% sO2 
and a phantom of 100% sO2, respectively. Supplementary 
Fig. 5c-d  present the sO2 estimation error of the eMSOT 
method (blue dots) and linear unmixing (red dots) for all 
analyzed pixels sorted per imaging depth.  
 Supplementary Fig. 5e-f present the application of the 
eMSOT method in the case of an unknown, non-uniform sO2 
background phantom with an insertion of 0% sO2 blood. The 
eMSOT grid is placed appropriately to cover the insertion 
area. Supplementary Fig. 5g-h present the initial spectrum in 
the insertion area (P(r,λ)) and the sO2 estimation using linear 
unmixing (g) as well as the corrected spectrum (PeMSOT(r,λ)) 
and sO2 estimation using eMSOT method (h).  
Supplementary Fig. 5i summarizes the sO2 estimation error 
of linear unmixing (red) and eMSOT method (blue) 
corresponding to the insertion area in the case of 8 different 
blood phantoms (4 different backgrounds and 2 different 
insertions per background). eMSOT offers higher accuracy 
with an sO2 estimation that is typically less than 10%, as 
opposed to linear unmixing that can be associated with errors 
as high as 30%. Finally, Supplementary Fig. 5i presents the 
fitting residual of linear (red) and eMSOT unmixing (blue) in 
each case.  
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Supplementary Figure 5. Validation of eMSOT using blood 
phantoms.  (a, b) eMSOT sO2 estimation in the case of a uniformly 
deoxygenated blood phantom (a) and a uniformly oxygenated 
phantom (b). Scale bar, 1 cm. (c, d) sO2 estimation error of eMSOT 
(blue dots) and linear unmxing (red dots) sorted per depth in the case 
of the deoxygenated phantom (c) and oxygenated phantom (d).  (e, f) 
eMSOT grid application (e) and sO2 estimation (f) in the case of a 
blood phantom containing an insertion of 0% sO2. Scale bar, 1 cm. 
(g, h) Spectral fitting and sO2 estimation in the insertion area using 
linear unmixing (g) and eMSOT (h). (i) Statistics on the sO2 
estimation error of eMSOT (blue) and linear unmixing (red) 
corresponding to the insertion region of eight different phantoms of 
varying background and target oxygenations. (j) Statistics on the 
fitting residual of eMSOT (blue) and linear unmixing (red) 
corresponding to the insertion region of eight different phantoms of 
varying background and target oxygenations.   
 
Supplementary Note 5: Application of eMSOT on 
experimental tissue images 
In experimental tissue data (muscle and tumor analysis) 
the prior ḿ1 and ḿ3 maps were computed as described in 
Supplementary Note 2 by using a 3D light propagation 
model and 20 sO2 maps corresponding to 20 consecutive 
MSOT slices (with a step size 0.5 mm) surrounding the central 
slice to be analyzed (Supplementary Figure 6a). This was 
performed in order to provide robust Eigenfluence prior 
estimates even in cases of substantial sO2 variations in the 3D 
illuminated volume (MSOT illumination width ~ 1 cm). 
Supplementary Figure 6b presents the prior ḿ1 map 
corresponding to an animal imaged post-mortem after CO2 
breathing.  
eMSOT accuracy depends on the quality of the measured 
optoacoustic spectra in the grid area. For ensuring successful 
application, an image area of high intensity (high SNR) and 
fidelity (visually presenting no reconstruction artefacts e.g. 
due to ill ultrasound coupling) and typically corresponding to 
the central-upper part of the image (corresponding to the focal 
area of the ultrasound sensors and eliminating the possibility 
of reconstruction artefacts due to the limited angle of 
coverage) was selected for applying the eMSOT method. 
Upon manual segmentation of an area, a circular grid is 
automatically applied in the image domain (Supplementary 
Figure 6c). The grid point location is automatically updated 
so that the points occupy the highest intensity pixels in their 
local vicinity. Grid points that correspond to image values 
under a predefined threshold (i.e. red points in 
Supplementary Figure 6c) are excluded from the inversion. 
The measured optoacoustic spectra corresponding to the grid 
points are in the following used in the context of the 
constrained inversion algorithm described in Methods and 
Supplementary Note 2 to obtain estimates of m1(r), m2(r) and 
m3(r) for each grid point r. Supplementary Figure 2d 
presents the prior ḿ1(r) (blue line), the limits of search space 
(blue vertical lines) and the m1(r) estimated by the constrained 
inversion (red line) for a radial line of the grid in 
Supplementary Figure 6c.  
Upon the estimation of m1(r), m2(r) and m3(r) in all grid 
points, the Eigenfluence maps for the intermediate grid points 
are computed by means of cubic interpolation (see Methods). 
Supplementary Figure 6e, f presents the m2 (e) and m1 (f) 
Eigenfluence maps corresponding to the same tissue area 
imaged under different physiological conditions, namely post-
mortem after CO2 breathing (left), in-vivo under 20%O2 
breathing (middle) and in-vivo under 100%O2 breathing 
(right). While the m2 map that corresponds mainly to tissue 
depth remains relatively unchanged under all three 
physiological conditions, m1 that corresponds more to 
background tissue oxygenation presents substantial differences 
between the three different states. The Eigenfluence maps are 
used to correct for the wavelength dependence of light fluence 
in the selected tissue area (Methods) and in the following 
blood oxygen saturation maps are computed using non-
negative constrained least squares fitting of the corrected 
eMSOT image with the spectra of oxy- and deoxy-hemoglobin 
(Supplementary Figure 6g). Pixels that are associated with a 
fitting residual above a certain threshold are excluded from the 
sO2 maps. 
After eMSOT inversion, the raw optoacoustic spectra (blue 
lines in Supplementary Figure 6h left) are decomposed into 
the element-wise product of the corrected normalized 
absorption spectra (blue lines in Supplementary Figure 6h 
middle) and the estimated light fluence spectra 
(Supplementary Figure 6h right). While linear fitting with 
the spectra of oxy- and deoxy-hemoglobin results in a high 
fitting residual and an inaccurate sO2 estimation when applied 
on the raw optoacoustic spectra (red lines in Supplementary 
Figure 6h left), it results in a low fitting residual after eMSOT 
correction (red lines Supplementary Figure 6h middle) 
independently of tissue depth.  
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Supplementary Figure 6. eMSOT application in experimental tissue images. (a) Initial sO2 maps corresponding to multiple MSOT slices 
surrounding the central slice to be analyzed. (b) Prior ḿ1 map computed using a 3D light propagation model and the initial sO2 maps as 
described in Supplementary Note 2. (c) Selection of a high intensity area in a well-reconstructed part of the image for the automatic 
application of a grid for eMSOT application. Scale bar, 1 cm. (d) Prior ḿ1 (blue line), limits of search space (blue vertical lines) and estimated 
m1 after eMSOT inversion, corresponding to a radial line of the grid in (c). (e-g) m2 (e), m1 (f) and sO2 maps (g) computed after eMSOT 
inversion for the same tissue area under three different physiological conditions. (h) Original optoacoustic spectra (P(r,λ); left, blue), eMSOT 
spectra (PeMSOT(r,λ); middle, blue) and estimated spectrum of light fluence (right) corresponding to a deep tissue point (yellow arrow in g). The 
spectral fitting with the spectra of oxy- and deoxygenated haemoglobin (red) and the estimated sO2 value and fitting residual are also presented 
in each case.  
 
Supplementary Note 6: Imaging tumor hypoxia with 
eMSOT and histological validation 
N=8 mice, bearing orthotopically implanted 4T1 mammary 
tumors were imaged with MSOT at transverse slices in the 
lower abdominal area (schematic representation in 
Supplementary Figure 7a). Supplementary Figure 7b 
presents an anatomical optoacoustic image showing a slice 
which corresponds approximately to the central section of the 
tumor. The tumor region (upper right part of the image) can be 
recognized as it displays an enhanced contrast and different 
anatomic characteristics as compared to the symmetric normal 
tissue region. The tumor region is manually segmented 
(dashed segmentation line, Supplementary Figure 7b). The 
eMSOT grid is set to cover the tumor area as well as adjacent 
normal tissue (Supplementary Figure 7b right).  
After MSOT imaging, the mice were sacrificed and 
prepared for histological analysis. A subset of the mice (n=4) 
were examined for tumor and tissue anatomy. Following 
MSOT acquisition, the mice were frozen and the lower 
abdominal region containing the tumor mass (dashed lines in 
Supplementary Figure 7c) was cryosliced in transversal 
orientation, similar to the one of MSOT imaging (see 
Supplementary Figure 7a). True color images of the whole 
body, including the tumor mass, were obtained and 
histological slices derived thereof were isolated for H&E 
staining. Supplementary Fig. 7d-g presents an anatomical 
optoacoustic image at the central tumor cross-section (d), the 
corresponding cryoslice true color photography (e), H&E 
tumor staining (f) and eMSOT sO2 analysis (g). The cryoslice 
true color photography displays the tumor heterogeneity, 
presenting sub-regions with prominent red color (marked in 
Supplementary Fig. 7e with an asterisk). These central 
necrotic areas, appearing to be suffused with blood, spatially 
correlate to the central hypoxic region in the core of the tumor 
as identified in the eMSOT image (Supplementary Figure 
7g; marked with an asterisk). Central necrotic areas could be 
confirmed by H&E staining  (Supplementary Figure 7f).    
Another subset of the mice (n=4) was examined for 
functional characterization of the tumors through 
CD31/Hoeachst33342/Pimodinazole histological staining. 
Throughout this process, the tumors were excised and the 3D 
orientation of the tumor with regard to the MSOT image was 
retained (Supplementary Fig. 7h, lower picture). In the 
following, the excised tumors were sectioned and ~8 µm thick 
slices were immunohistochemically stained for studying 
micro-vascularization (CD31 staining) and cellular hypoxia 
(Pimonidazole staining). Vascular perfusion was determined 
following Hoechst33342 detection.   
Supplementary Fig. 7i presents the eMSOT sO2 
estimation of two tumors presenting different levels of 
oxygenation. The tumor areas, as identified by the anatomical 
images, are segmented with a yellow dashed line. The average 
sO2 levels of the central tumor areas (blue dashed rectangle) 
are further displayed in the image. The corresponding CD31 
staining, as shown in Supplementary Fig. 7j  reveals a dense 
tumor microvasculature in both tumors. This might explain the 
high tumor contrast in optoacoustic imaging. Hoechst 33342 
staining (Supplementary Fig. 7k) reveals substantial 
differences in the perfusion patterns of the two tumors, with 
the first tumor appearing to be perfused  both in the boundary 
(grey dashed box) and the core (green dashed box). In an 
effort to quantify the perfusion patterns, the ratio of the 
Hoechst image intensity in the core vs the boundary was 
computed (intensity ratio 48%). The second tumor displays 
less perfusion in the core, as compared to the boundary 
(intensity ratio 19%). This finding indicates less functionality 
of the microvasculature in the core, which might explain the 
lower eMSOT sO2 values as compared to the first tumor. The 
less perfused tumor areas (dark areas in k) appear spatial 
congruence with the areas of reduced blood oxygenation 
revealed by eMSOT (i). The non-perfused tumor areas further 
appear spatially correlated to cell hypoxia as identified by 
Pimonidazole staining (l, green). Cell hypoxia, as determined 
by Pimonidazole staining, may be a consequence of both, 
perfusion hypoxia (revealed by Hoechst33342 and eMSOT) 
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and also diffusion hypoxia, which does not display eMSOT 
signal. Although, due to technical reasons, it may be 
challenging to achieve exact co-registration between in-vivo 
eMSOT tumor images and ex-vivo histology, the presented 
histological analyses demonstrate the ability of eMSOT to 
detect perfusion related hypoxia within solid tumors. 
Furthermore, clear discrimination of different levels of 
hypoxia within single tumors, as well as intratumoral hypoxia-
related heterogeneity could be demonstrated.  
 
 
 
Supplementary Figure 7. Histological validation of tumor imaging and co-registration. (a) Schematic representation of MSOT imaging at 
a transversal slice within the tumor area (b) Cross-sectional optoacoustic image at a central tumor transversal slice. The tumor region is 
segmented with a dashed line. The eMSOT grid is further presented (blue and red dots). (c)Image of the lower abdominal area displaying the 
orthotopic mammary tumor. Dashed lines present the orientation of cryoslicing and MSOT imaging. (d-g) Anatomical optoacoustic image (d; 
Scale bar, 1cm) and the corresponding cryosliced color photography (e), H&E staining of the tumor region (f; Scale bar, 2mm) and eMSOT 
sO2 analysis of the tumor area (g). (h, lower) Excised tumor used for functional staining. Yellow dashed lines indicate the slicing orientation. 
(i-l) Examples of a highly perfused (upper row) and low perfused (lower row) tumor analysed with eMSOT for sO2 estimation (i), CD31 
staining (j), Hoeachst33342 staining (k), and merged with Pimonidazole staining (l). Scale bar, 2mm. The tumor margins are presented in (i) 
indicated by yellow dashed lines. Blue dashed rectangles indicate a region in the tumor core, the average sO2 values of which are displayed on 
the upper right. The intensity ratio of Hoechst33342 staining was calculated by dividing the mean intensity value in the tumor core (green 
dashed rectangle in (k)) over the one in the tumor boundary (grey rectangle in (k)). 
 
 
Supplementary Figure 8. Comparison of healthy tissue and 
tumor sO2 measurements under a breathing challenge. (a-c) 
Healthy tissue (left) and tumor (right) sO2 estimation post-mortem 
after CO2 breathing (a) and in-vivo under 20%O2 (b) and 100% O2 
breathing (c). 
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